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Abstract: This study examined the cell-to-cell in-
teraction between fibroblasts and macrophages as a
possible contributor to the chronic inflammatory
state. In a coculture system, consisting of macro-
phages layered over confluent fibroblasts, there
was a significant increase in macrophage inflamma-
tory protein 1a (MIP-1a) compared with control
cultures. ICAM-1 adhesion was identified as an
important stimulus of MIP-1a production by using
ICAM-1-specific monoclonal antibodies. Further-
more, fibroblasts from ICAM-1 knockout mice
induced significantly less MIP-1a production from
peritoneal macrophages when compared to control
fibroblasts. In addition, it appeared that oxygen
radicals functioned as activating molecules during
cellular interaction and production of MIP-1a, as
the addition of the antioxidant N-acetylcysteine
(NAC) prevented MIP-1a secretion. Thus, the
ICAM-1 and oxygen radical-mediated induction of
MIP-1a associated with a macrophage/fibroblast
coculture system provides one possible mechanism
by which immune/inflammatory cell interactions
may augment chemokine production and exacer-
bate chronic inflammatory diseases. J. Leukoc.
Biol. 64: 636–641; 1998.
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INTRODUCTION
Inflammatory/immune cell influx is a necessary response to
pathogenic invaders, facilitating the timely eradication of
pathogens. Often, however, after the infecting agent has been
cleared, the immune response persists and immune cells
continue to infiltrate previously infected tissues. This pattern of
chronic inflammation has been extensively documented, espe-
cially in the context of fibrotic diseases [1]. Furthermore, the
persistent recruitment of monocytes to fibrotic tissue has been
identified as a major component in the progression of chronic
inflammatory diseases [2]. Leukocyte recruitment is initiated
by adhesion molecules on the surfaces of endothelial cells,
whereas chemokines and other chemotactic factors mediate the
recruitment and extravasion of selective cell populations to
target tissues [3]. The chemokines are categorically divided
into the CxC (or alpha) chemokines and the CC (or beta)
chemokines. However, two recently discovered chemotactic
proteins, lymphotactin and fractalkine, may warrant new famil-
ial designations as C and CxxxC chemokines, respectively.
Although the chemokines were originally described as leuko-
cyte chemoattractants, these small proteins have more recently
been characterized as versatile mediators of acute and chronic
inflammation because they function in angiogenesis, fibrogen-
esis, immune cell activation/regulation, and chemotaxis [4, 5].
Macrophage inflammatory protein 1a (MIP-1a) is a member of
the CC chemokine family and is produced primarily by
leukocytes, but not by stromal or structural cells. Once immune
cells enter the target tissue or organ they continue to interact by
cell-to-cell contact with structural cells. Earlier studies have
demonstrated that monocyte/macrophage interactions with vari-
ous cell populations can induce the production of chemokines
[6]. These types of interactions may contribute to the persistent
influx of leukocytes that characterizes chronic fibrotic diseases.
This study focuses on mechanisms by which cell-to-cell
interactions may contribute to the pathological progression of
chronic fibrotic diseases through specific interactions between
an immune (macrophage) cell and a nonimmune stromal cell
(fibroblast). These interactions appear to be mediated in part by
ICAM-1-dependent adherence, which can lead to activation of
a respiratory burst [7]. Furthermore, these oxygen radicals have
been shown to induce chemokine production [8]. We found that
in the absence of any pathogenic insult, the interaction between
macrophages and fibroblasts, partially driven by the ICAM-1-
mediated contact event, results in a significant increase in
MIP-1a production. In addition, this chemokine release ap-
pears to be mediated via the generation of oxygen radical
intermediates.
Abbreviations: MIP-1a, macrophage inflammatory protein 1a; DMEM,
Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; TNF-a, tumor
necrosis factor a; IL-1, interleukin-1; ELISA, enzyme-linked immunosorbent
assay; PBS, phosphate-buffered saline; BSA, bovine serum albumin; IPF,
idipathic pulmonary fibrosis.
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MATERIALS AND METHODS
Animals
Specific pathogen-free CBA/J mice (6- to 12-week-old females, Charles River
Breeding Labs) were used in all experiments requiring primary cell isolates. All
mice were housed in specific pathogen-free conditions within the animal care
facility at the University of Michigan (ULAM) until the day they were killed.
Peritoneal macrophage isolation
Mice were anesthetized and killed. The peritoneal cavity was exposed and
approximately 10 mL of sterile 0.05 M EDTA solution was injected into the
peritoneal cavity with a 26-gauge needle. A second needle was then inserted
along a lateral side of the peritoneal cavity and the majority of the EDTA
solution was withdrawn. This procedure was repeated approximately three
times per mouse. On removal from the peritoneal cavity, the cell-containing
EDTA solution was immediately placed on ice. The cells were pelleted by
centrifugation at 1500 rpm after which the red blood cells were lysed using an
ammonium chloride red blood cell lysing buffer. The cells were washed twice in
RPMI, after which they were resuspended in 15% Dulbecco’s modified Eagle’s
medium (DMEM).
Fibroblast isolation/culture
Lung fibroblasts were cultured from ICAM-1 knockout and wild-type CBA/J
mice as previously described [9]. Briefly, whole lungs were removed from
exsanguinated mice and transferred to RPMI 1640 containing 10% fetal bovine
serum (FBS). The lung tissues were then ground into single cell preparations,
after which red blood cells were lysed with an aluminum chloride-containing
hypotonic lysing buffer for 2 min at 4°C. The remaining lung cells were then
added to 175-mL tissue culture flasks. Cells were grown at 37°C in a
humidified CO2 incubator and fed DMEM containing 1% (v/v) antibiotic-
antimycotic and 15% (v/v) FBS twice per week. After a minimum of two
passages, homogenous fibroblast populations were transferred to six-well
culture plates for experiments. Before experimental use, the fibroblast pheno-
type was confirmed in all cells by staining for a-actin and desmin in two-well
Labtekt chamber culture slides. All fibroblasts were found to be completely
free of a-naphthyl acetate esterase-positive macrophages.
Cell lines
Experiments to evaluate macrophage/fibroblast coculture-induced MIP-1a
production were conducted with macrophage and fibroblast cell lines obtained
from American Type Culture Collection (Rockville, MD). The murine fibro-
blasts cell line CL.7 (ATCC no. TIB 80) and the murine macrophage line RAW
264.7 (ATCC no. TIB 71) were cultured in DMEM containing 1% (v/v)
antibiotic-antimycotic and 15% (v/v) FBS at 37°C in a humidified CO2
incubator.
Reagents
Polyclonal tumor necrosis factor a (TNF-a), interleukin-1 (IL-1), and JE
specific antiseras were generated in New Zealand White rabbits by multiple
site immunization with recombinant murine cytokine/chemokine (R & D
Systems, Minneapolis, MN) in complete Freund’s adjuvant as previously
described [10]. Polyclonal antibodies were titered by direct enzyme-linked
immunosorbent assay (ELISA), and antibody specificity was verified for each
ELISA.
Monoclonal antibodies to murine ICAM-1 (R & D Systems) and murine
VCAM-1 (Chemicon International, Temecula, CA) were utilized in adhesion
blocking experiments.
Murine cytokine ELISA
Murine MIP-1a was quantitated using a modification of a double-ligand
method as previously described [11]. Briefly, flat-bottomed 96-well microtiter
plates (Nunc Immuno-Plate I 96-F) were coated with 50 mL/well of rabbit
antibody against the various cytokines (1 mg/mL in 0.6 M NaCl, 0.26 M H3BO4,
and 0.08 M NaOH, pH 9.6) for 16 h at 4°C and then washed with
phosphate-buffered saline (PBS), pH 7.5, 0.05% Tween-20 (wash buffer).
Microtiter plate nonspecific binding sites were blocked with 2% bovine serum
albumin (BSA) in PBS and incubated for 90 min at 37°C. Plates were rinsed
four times with wash buffer and diluted (neat and 1:10) cell-free supernatants
(50 mL) in duplicate were added, followed by incubation for 1 h at 37°C. Plates
were washed four times, followed by the addition of 50 mL/well biotinylated
rabbit antibodies against the specific cytokines (3.5 mg/mL in PBS, pH 7.5,
0.05% Tween-20, and 2% FCS), and plates incubated for 30 min at 37°C.
Plates were washed four times, streptavidin-peroxidase conjugate (Bio-Rad
Laboratories, Richmond, CA) added, and the plates incubated for 30 min at
37°C. Plates were washed again four times and chromogen substrate (Bio-Rad
Laboratories) added. The plates were incubated at room temperature to the
desired extinction, and the reaction terminated with 50 mL/well of 3 M H2SO4
solution. Plates were read at 490 nm in an ELISA reader. Standards were 1/2
log dilutions of recombinant murine cytokines from 1 pg/mL to 100 ng/mL. This
ELISA method consistently detected murine cytokine concentrations above 25
pg/mL. Antibody specificity was verified for each ELISA.
Statistical analysis
Data were evaluated by analysis of variance followed by two-tailed t test. All
calculations were performed on a Power Macintosh 7200 computer, using Prism
2.0 (Graphpad Software, Inc., San Diego, CA). Significance was assigned for P
values , 0.05.
RESULTS
MIP-1a production resulting from
fibroblast/macrophage interaction
Prior studies have demonstrated that immune/non-immune cell
interactions can induce chemokine production [11]. The pri-
mary intent of this study was to address whether this specific
macrophage/fibroblast interaction was sufficient to induce the
production of MIP-1a, a known inflammatory cytokine that is
also chemotactic for monocytes. We first characterized the
MIP-1a production associated with the addition of varying
numbers of RAW cells to confluent CL7 fibroblast cultures
(Fig. 1). The CL7/RAW cell cocultures produced a significant
increase in MIP-1a production compared with control cultures.
Furthermore, this increased production was clearly dependent
on the number of RAW cells involved as we observed a
threefold increase in production with 5 3 105 RAW cells versus
5 3 104 RAW cells. We also examined the kinetics of MIP-1a
production in the CL7/RAW cell coculture system (Fig. 2). We
found that increased MIP-1a secretion was already evident
after 1 h of coculture. MIP-1a production peaked at 24 h, but
was still prevalent at 48 h. Thus, we focused subsequent
experiments on the 24-h time-point. It is interesting to note that
CL7s appeared to specifically up-regulate MIP-1a expression.
Of the chemokines examined, including MIP-1b, C10, MIP-2,
KC, ENA-78, eotaxin, and JE, only MIP-1a production was
significantly elevated in CL7/RAW cocultures.
ICAM-1 as a mediator of MIP-1a production
To determine the possible role of ICAM-1 in MIP-1a produc-
tion resulting from the CL7/RAW cell interaction, purified
ICAM-1-specific monoclonal antibodies were used to neutral-
ize cell-surface expression of the adhesion molecule (Fig. 3).
ICAM-1-specific antibodies significantly inhibited the MIP-1a
production associated with the CL-7/RAW cell coculture,
suggesting that ICAM-1 played a role in the production of
MIP-1a during this cellular interaction. Furthermore, in a
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primary cell isolate coculture system, consisting of peritoneal
macrophages and lung fibroblasts isolated from ICAM-1 knock-
out mice, MIP-1a production was significantly decreased
compared to a coculture system with control fibroblasts (Fig.
4). When control fibroblasts were separated from the peritoneal
macrophage population by a transwell membrane (which allows
the passage of soluble factors but prevents physical contact
between the two cell populations), about 50% of coculture-
induced MIP-1a production was prevented. These results
suggest that ICAM-1 ligation clearly mediates a substantial
portion of the adhesion-induced MIP-1a production. However,
in the absence of ICAM-1 (as with the fibroblasts from ICAM-1
knockout mice), it appears that other events can also induce
MIP-1a production.
Macrophage/fibroblast coculture-induced MIP-1a
production is not dependent on TNF-a, IL-1,
or JE
TNF-a, IL-1, and JE have previously been implicated as
regulators of chemokine production and adhesion molecule
expression [12–14]. Thus, we explored the possibility that these
cytokines might be directly or indirectly involved in the
macrophage/fibroblast coculture-induced production of MIP-
1a. Accordingly, each of these cytokines was neutralized with
specific polyclonal rabbit antisera in the context of the
CL7/RAW coculture. When compared to CL7/RAW cocultures
treated with preimmune rabbit serum, none of the cytokine-
specific antibody treatments significantly affected MIP-1a
production (Fig. 5).
MIP-1a production and its dependence on
oxygen radicals
Oxygen radicals have previously been identified to induce
MIP-1a gene transcription [8], whereas adhesion to ICAM-1
can induce an oxidative burst in mononuclear phagocytes [7].
Thus, to deduce a possible role for oxygen radicals in the
ICAM-1-induced production of MIP-1a, respiratory burst-
mediated activation was neutralized with the nonspecific
antioxidant N-acetylcysteine (NAC). In the CL7/RAW cocul-
ture system, MIP-1a production was reduced in a dose-
dependent manner (Fig. 6). NAC reduced MIP-1a levels by
Fig. 1. Effect of varying numbers of RAW cells on CL7/RAW coculture-
induced MIP-1a production. RAW cells were layered onto a CL7 monolayer.
RAW cell controls were layered onto a fixed CL7 monolayer (10 min with 4%
paraformaldehyde). MIP-1a concentrations were evaluated by ELISA after 24 h
of incubation. Data expressed as mean 1 SE of one experiment (n 5 3)
representing two experiments with similar results. *P , 0.01 or **P , 0.005 as
compared to fixed CL7 plus RAW control group.
Fig. 2. Time-course of CL7/RAW coculture-induced MIP-1a production.
RAW cells (105/well) were layered onto a CL7 monolayer. MIP-1a concentra-
tions were evaluated by ELISA after 1, 4, 8, 24, and 48 h of incubation. Data
expressed as mean 1 SE of one experiment (n 5 3). Subsequent experiments
displayed similar trends.
Fig. 3. Result of cell surface neutralization of ICAM-1 on MIP-1a production
from CL7/RAW coculture. RAW cells (105/well) were layered onto a CL7
monolayer. RAW cell controls were layered onto a fixed CL7 monolayer (10 min
with 4% paraformaldehyde). CL7/RAW cocultures were treated with monoclo-
nal antibodies to ICAM-1 or VCAM-1. MIP-1a concentrations were evaluated
by ELISA after 24 h of incubation and expressed as mean 1 SE. Experimental n 5 3.
However, this figure is representative of data from three similar experiments.
*P , 0.05 as compared to CL7 1 RAW group.
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approximately 75 and 90% at 10 and 20 mM concentrations,
respectively. At 50 mM, NAC completely abrogated MIP-1a
production. Therefore, it appears that during fibroblast/
macrophage interaction, oxygen radicals are necessary cofac-
tors for MIP-1a production.
DISCUSSION
Chronic inflammatory and/or fibrotic disease results from a
failure to resolve the immune response after the clearance of the
inciting agent. The chronic disease state is characterized by
several departures from the homeostatic environment of the
tissue, including abnormal cytokine production, persistent
infiltration of immune cells, and often an unnecessary deposi-
tion of matrix proteins [15]. This study explored one possible
contributing mechanism by which chemokine production can
become activated in the absence of any pathogenic challenge.
Previously, we have shown that chemokine production could be
induced by immune/non-immune cell interactions without any
additional stimulus. Specifically, monocyte-endothelial cell
interactions can induce the production of IL-8, MCP-1, and
MIP-1a [11]. However, it has not been shown that immune/non-
immune cell interactions can maintain chemokine production
after the immune cell has entered the target tissue. We
suspected that, as immune cells extravasate through the
endothelium and infiltrate tissues, they can interact with other
stromal cell types, resulting in elevated chemokine production.
The specific cell-to-cell interaction between macrophage and
fibroblast cell lines was chosen because macrophages represent
Fig. 4. Differential effects of normal fibroblasts versus ICAM-1 knockout
fibroblasts (F) on peritoneal macrophage (PM)-derived MIP-1a, and the role of
soluble and adhesive factors in the observed coculture-induced MIP-1a
production. Peritoneal macrophages (105/well) were layered onto a fibroblast
monolayer. PM controls were layered onto a fixed fibroblast monolayer (10 min
with 4% paraformaldehyde). In the TRANSWELL group, the two cell popula-
tions were physically separated by a membrane that allows the passage of
culture media plus any soluble factors. MIP-1a concentrations were evaluated
by ELISA after 24 h of incubation and expressed as mean 1 SE. Data
representative of two different experiments, experimental n 5 6. *P , 0.01,
**P , 0.0001 as compared to FIBRO 1 PM group.
Fig. 5. The immunoneutralization of TNF-a, IL-1, and JE in the context of
CL7/RAW cocultures, and the resultant effect on MIP-1a production. RAW
cells (105/well) were layered onto a CL7 monolayer. RAW cell controls were
layered onto a fixed CL7 monolayer (10 min with 4% paraformaldehyde).
CL7/RAW cocultures were treated with preimmune serum (PS) or polyclonal
antisera to TNF-a, IL-1, or JE. MIP-1a concentrations were evaluated by
ELISA after 24 h of incubation and expressed as mean 1 SE. Experimental
n 5 6.
Fig. 6. Effect of N-acetylcysteine repression of macrophage super radical
production on CL7/RAW coculture-induced MIP-1a levels. RAW cells (105/
well) were layered onto a CL7 monolayer. RAW cell controls were layered onto a
fixed CL7 monolayer (10 min with 4% paraformaldehyde). MIP-1a concentra-
tions were evaluated by ELISA after 24 h of incubation and expressed as
mean 1 SE. Data representative of two different experiments; experimental n 5
3–6. *P , 0.0001 as compared to CL7 1 RAW group.
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a major infiltrating immune cell population during chronic
inflammatory disease and fibroblasts are commonly found
dispersed throughout all tissue types, especially in and around
fibrotic lesions. Fibroblast/macrophage coculture-induced
MIP-1a production was initially found to depend on the
number of macrophages, suggesting that MIP-1a production
may be a self-perpetuating event, dependent on macrophage
interactions with inflammatory fibroblasts. This may be an
important issue because of this cytokine’s role both as a
chemotactic agent and as an immune activator. Specifically,
MIP-1a has been described as a potent monocyte/macrophage
chemoattractant, and as a macrophage activator, inducing the
production of other inflammatory mediators such as IL-1 and
TNF-a [16–18]. Furthermore, in the context of the fibrotic
disease state, MIP-1a production has been associated with
disease severity. For example, in both a murine model of
bleomycin-induced pulmonary fibrosis and in human patients
diagnosed with idiopathic pulmonary fibrosis (IPF), MIP-1a
production was elevated when compared to control animals/
patients [19]. In addition, in the bleomycin model, neutraliza-
tion of MIP-1a attenuated disease severity [20]. Thus, chronic,
self-perpetuation of MIP-1a production, as observed in the
fibroblast/macrophage coculture system, presents a threat to
host tissues, and is especially relevant in the context of fibrosis.
The progression of fibrotic disease also depends in part on
the expression of various adhesion molecules because they are
vital facilitators of immune cell extravasation through the
endothelium [21]. However, we have also identified the possibil-
ity of adhesion molecule mediation of chemokine production
during chronic inflammatory states. The b-integrins, for ex-
ample, can mediate immune/non-immune cell adhesion events,
spurring chemokine production [unpublished observations].
Furthermore, monocyte interaction with ICAM-1 (which binds
b2-integrins) on the surface of endothelial cells induced the
expression of MIP-1a, whereas VCAM-1 seemed to have no
role [11]. This study examined the role of both ICAM-1 and
VCAM-1 adhesion molecules by using specific antibodies to
neutralize their cell-surface expression. In this fibroblast/
macrophage system, VCAM-1 appeared to have no role in the
observed elevation in MIP-1a production, whereas the neutral-
ization of ICAM-1 significantly inhibited MIP-1a production.
In the coculture system, ICAM-1 knock out fibroblasts induced
significantly less MIP-1a production compared with control
fibroblasts. Although the reduction of MIP-1a was not as
impressive as the anti-ICAM-1 data on the fibroblast cell line,
it reiterated that ICAM-1 is an important adhesion molecule in
the contact-induced production of MIP-1a. Although this study
focused on the role of ICAM-1 in adhesion-induced chemokine
expression, additional adhesion events probably participate in
the up-regulation of MIP-1a production. CD44-mediated adhe-
sion, for example, may account for some portion of the
contact-induced MIP-1a production because it has previously
been shown that CD44 binding of hyaluronan can result in
MIP-1a production [22, 23]. It is interesting to note that the
transwell membrane (which prevented the two cells’ popula-
tions from physically interacting) only reduced MIP-1a produc-
tion by 50% compared to fibroblast/macrophage coculture
controls, suggesting that soluble factors in addition to adhesion
molecules may also play a role in the induction of MIP-1a
production. Furthermore, in the context of the CL7/RAW
coculture system separated by transwell membrane, the addi-
tion of anti-ICAM-1 did not affect MIP-1a production, again
suggesting an alternate mechanism of coculture-induced MIP-1a
up-regulation (data not shown). In light of the possible role for
soluble factors in the coculture-induced secretion of MIP-1a,
we explored the possibility that a soluble cytokine signal was
directly or indirectly responsible for the increased MIP-1a
production. Several key proinflammatory cytokines, including
TNF-a, IL-1, and JE, were immuno-neutralized in the context
of CL7/RAW cocultures. However, none of the latter neutraliz-
ing conditions affected MIP-1a production compared to control
cultures. Thus, because the proinflammatory cytokines IL-1,
TNF-a, and JE do not appear to affect MIP-1a production, and
because ICAM-1-mediated interactions cannot account for all
of the coculture-induced MIP-1a production, other factors (i.e.,
interactions with matrix proteins, other adhesion molecules, or
soluble factors) probably play a role in the observed levels of
MIP-1a secretion.
Oxidants have been identified as important components of
fibrotic disease because they not only directly damage tissues,
but they additionally stimulate collagen production and the
generation of fibrotic tissues [24]. This study examined oxygen
radical participation in the stimulation of MIP-1a during
macrophage/fibroblast interactions. It has previously been
shown that cross-linking of ICAM-1 induces an oxidative burst
from monocytes [7]. Furthermore, oxygen radicals have been
identified as important effectors of chemokine production,
including MIP-1a [8, 25]. In this study, the role of the
respiratory burst in MIP-1a induction was characterized by
inhibiting oxygen radical regulatory functions with the antioxi-
dant NAC. In the macrophage/fibroblast coculture system,
NAC suppressed MIP-1a production in a dose-dependent
manner, completely neutralizing MIP-1a production at a 50
mM concentration. Furthermore, NAC effectively neutralized
all MIP-1a production associated with CL7/RAW cocultures
separated by a transwell membrane (data not shown), further
implying that mechanisms of coculture induced MIP-1a produc-
tion operating independently of ICAM-1 must ultimately de-
pend on the elicitation of oxygen radicals. Thus, the respiratory
burst appears to be a necessary cofactor for MIP-1a secretion in
this macrophage/fibroblast coculture system, which may be
pertinent to MIP-1a regulation, as our preliminary studies show
that IL-1 and TNF-a are poor inducers of MIP-1a in monocytes
compared to cell-to-cell interactions [unpublished data].
Overall, the results of this study indicate that during
macrophage/fibroblast interactions substantial MIP-1a produc-
tion is induced, and this event is dependent on ICAM-1-
mediated ligation and oxidative burst activation. Although this
mechanism by which a stromal cell activates immune cell-
derived chemokine production could be relevant to various
different inflammatory states, these data may be especially
important during chronic disease because: (1) MIP-1a is a
potent chemoattractant for macrophages, (2) MIP-1a functions
as a macrophage activator, and (3) prolonged maintenance of
these latter MIP-1a effects correlate with the pathogenesis of
chronic diseases.
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